Spire Wealth Management’s Oragenics OGEN Stock Holding History

Spire Wealth Management’s Portfolio OGEN Stock Details OGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4	Closed	-$1K	–	2561
2022 Q4	$1K	Hold	4	–	–	﹤0.01%	2222
2022 Q3	$2K	Hold	4	–	–	﹤0.01%	1976
2022 Q2	$2K	Hold	4	–	–	﹤0.01%	2383
2022 Q1	$2K	Sell	4 -4	-50%	-$2.93K	﹤0.01%	2409
2021 Q4	$7K	Buy	8 +1	+14%	+$1.01K	﹤0.01%	2491
2021 Q3	$8K	Hold	7	–	–	﹤0.01%	2166
2021 Q2	$8K	Sell	7 -2	-22%	-$2.63K	﹤0.01%	2205
2021 Q1	$15K	Buy	+9	New	+$16.3K	﹤0.01%	2270

Other funds holding OGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

WWM

Wolff Wiese Magana Carslbad, California $217M AUM 47.64% 1-Year Est. Return

Spire Wealth Management's OGEN Position: Q1 2023 in Review

Spire Wealth Management sold out of Oragenics (OGEN) in Q1 2023, closing a stake of 4 shares — an estimated $1K sold.

Spire Wealth Management first reported a position in OGEN in Q1 2021 and held it in 8 quarters. The position peaked at $15K in Q1 2021. 10 funds tracked by Wall St. Rank hold OGEN as of Q1 2023.

Spire Wealth Management reported no remaining Oragenics position as of Q1 2023 after selling out during the quarter.
Spire Wealth Management sold 4 Oragenics shares in Q1 2023, an estimated $1K.
Spire Wealth Management first reported a position in Oragenics in Q1 2021 and held it in 8 quarters.
Spire Wealth Management's Oragenics position peaked at $15K in Q1 2021.
10 funds tracked by Wall St. Rank held Oragenics as of Q1 2023.

Based on Spire Wealth Management's 13F filing for Q1 2023, filed 9 May 2023.